ALC logo

ALCON INC

ALCNYSE
Earnings Nov 10US Equity
$72.42β–Ό $2.82 (βˆ’3.89%)
Live
1hβ–² 0.3%
24hβ–Ό 3.9%
7dβ–² 2.7%
14dβ–² 4.0%
30dβ–² 5.0%
1yβ–Ό 15.8%
🏦Market Cap
$36.19B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+7.1%
Slowing
πŸ“ŠGross Margin
58.5%
Healthy
πŸ’΅FCF Margin
15.0%
Healthy
βš–οΈP/S Ratio
3.3x
Fair
Otter Score
57
Weak

Trading Snapshot

Day Range
$72.14 – $72.77
52-Week Range
$47.80 – $72.88
Volume
$2.43B
Avg Volume
$2.26B
Shares Outstanding
499.7M
Next Earnings
Sep 12, 2026

Fundamentals Snapshot

Annual Revenue
$10.40B
Last Q Revenue
$2.65B
P/E Ratio
43.3
P/S Ratio
3.3x
EPS (TTM)
$1.66
Dividend Yield
0.47%

Why Investors Own ALC

  • βœ“High-growth profile β€” revenue up -7.6% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 58% gross margin and 26% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$10.40Bβ–Ό βˆ’11.7% YoY
Gross Margin (TTM)
58.4%β–² +0.9% YoY
Operating Income (TTM)
$3.91Bβ–Ό βˆ’11.7% YoY
Free Cash Flow (TTM)
$2.74Bβ–Ό βˆ’11.7% YoY

About ALCON INC

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
57/100

Analyst Price Target

β“˜
Average Target
$95.82
β–² +32.3% Upside
High Target$118.67
Low Target$84.59
Based on 36 analysts

Latest News & Updates